Ricerca avanzata per:
Risultati della ricerca
-
101. Albo-dottori-XXV-ciclo-anno-2015 (15%)
25-lug-2017 12.19.00HISTONE DEACETYLASE INHIBITOR, ON CANCER CELLS FROM HUMAN BREAST EPITHELIUM 3/2/15 DOCTOR EUROPAEUS ... AND IN BREAST CANCER OPERATED PATIENTS UNDER CONTROLLED DIETS AND IN VITRO ASSESSMENT OF PLATELET ... IMMUNOFARMACOLOGIA - INTERNAZIONALE 25 TURDO ALICE PALERMO PA 28/02/1988 STEM CELLS IN BREAST CANCER
-
102. Lauricella CV Hypatia (15%)
15-lug-2013 10.14.46and anoikis of MDA-MB231 and MCF-7 breast cancer cells. BIOCHIMIE. 94(2):287-99. ISSN: 0300-9084 ... -independent cell death in osteosarcoma, melanoma and breast cancer cells through the induction ... effects of Parthenolide on MDA- MB231 breast cancer cells. 25° Convegno Annuale della Associazione
-
103. Albo-dottori-XXVI-ciclo-Anno-2016 (15%)
28-feb-2018 11.01.17PETRALIA SOTTANA PETRALIA SOTTANA PA XXVI CELL, MOLECULAR AND INFLAMMATORY BREAST CANCER RESPONSE ... FOR HEREDITARY BREAST AND/OR OVARIAN CANCER 3/14/16 Oncologia Clinica e Molecolare indirizzo in Oncologia ... MARKERS IN BREAST AND COLON CANCER 3/24/16 Scienze e Biotecnologie Mediche Sperimentali e Applicate
-
104. SCIENZE UROLOGICHE - Pavone (15%)
8-mar-2013 23.05.06originating from occult breast lobular carcinoma: diagnostic and therapeutic problems. World J Surg ... from occult breast lobular carcinoma: diagnostic and therapeutic problems. World J Surg Oncol. 2008 Jul ... a Conservative Therapeutic Approach? J Breast Cancer. 2012 Sep;15(3):371-2. doi: 10.4048/jbc.2012.15.3.371
-
106. 3 bando 2023 (15%)
6-apr-2023 10.34.49per la classificazione della malattia e la stratificazione del paziente. - Description: Breast cancer ... management of metastatic breast cancer. Research in the last decade has solidified the notion ... strategies for metastatic breast cancer, and new criteria for disease classification and patient
-
107. 3 english version bando 2023 (15%)
6-apr-2023 10.34.50- Description: Breast cancer is the most frequent tumor worldwide in women whose lethality is caused ... challenges in the clinical management of metastatic breast cancer. Research in the last decade has ... to reveal new therapeutic strategies for metastatic breast cancer, and new criteria for disease
-
108. TPVES da novembre 2021 (15%)
30-nov-2021 16.45.08Sofia - Cervello - Breast Unit (Faldetta) - 03/12/2021 - 02/01/2022 0618799 - PIETRO LUCIA Villa Sofia - Cervello - Breast Unit (Tutor 2) - 03/12/2021 - 02/01/2022 0628558 - ADA TARAVELLA TPVES ... Studi di Palermo - Scuola di Medicina e chirurgia - Ufficio Tirocini Villa Sofia - Cervello - Breast
-
109. 10 Verbale Collegio dei Revisori dei Conti 11 06 2019_sito (15%)
16-lug-2019 11.44.13underlying the resistance of breast cancer stem cells to anti-cancer therapies”- CUP B78D19000140007 ... 2018 Id 21492 con l’AIRC – “Identification of molecular events underlying the resistance of breast ... 21492 con l’AIRC – “Identification of molecular events underlying the resistance of breast cancer
-
111. TPVES luglio-settembre 2023 (15%)
28-giu-2023 9.39.30/07/2023 0590625 - FRANCESCA ARCOLEO Villa Sofia - Cervello - Breast Unit (Tutor 1) - 01/07/2023 - 31 ... - FRANCESCO ALAMIA SABBADINI SCHILLACI Villa Sofia - Cervello - Breast Unit (Tutor 2) - 01/08/2023 - 31 ... - Breast Unit (Tutor 1) - 01/09/2023 - 30/09/2023 0670143 - ELEONORA BOZZOTTA Civico - Medicina d'Urgenza
-
112. Prodotti della ricerca (15%)
16-ott-2023 11.28.32Microenvironment and Breast Cancer Cell - International Journal of Pharmaceutics (2019), DOI: 10.1016 ... . Feo - A multiomics analysis of S100 protein family in Breast Cancer - Oncotarget (2018), DOI ... protein family in Breast Cancer - Oncotarget (2018), DOI: 10.18632/oncotarget.25561; M. Ciabocco, P
-
113. RELAZIONE ATeN Center anno 2020 - 16 Settembre f.ta (15%)
26-gen-2023 10.25.01: G29J18000700007, Responsabile Scientifico: Prof. Salvatore Feo. − PRIN 2018 Titolo: Host breast tumour ... of breast cancer progression. Iris ID: PRJ0156 CUP: 2017T8CMCY_003, Responsabile Scientifico: Prof ... to Customize Hypofractionated Radiation Therapy in Breast Cancer - PRIN 2020 - Strutture UNIPA
-
114. RELAZIONE_ATeN_Center_anno_2021_-_20_Settembre_22_ (15%)
26-gen-2023 10.25.01: Host breast tumour microenvironment: study of key molecules secreted by stromal and tumour cells and ... on the enhancement of breast cancer progression. Iris ID: PRJ0156 CUP: 2017T8CMCY_003, Responsabile ... Survival Rate (LSR) Application to Customize Hypofractionated Radiation Therapy in Breast Cancer - PRIN
-
115. Principali Prodotti della Ricerca (15%)
3-dic-2020 12.17.22Embedded in Polyamino acid Nanogels to Synergistically Treat Tumor Microenvironment and Breast Cancer ... Minafra, S. Feo - A multiomics analysis of S100 protein family in Breast Cancer - Oncotarget (2018), DOI ... of S100 protein family in Breast Cancer - Oncotarget (2018), DOI: 10.18632/oncotarget.25561; M
-
116. CV_Alessandro Perez (15%)
5-dic-2016 8.28.06Breast and Ovarian Cancer syndrome (HBOC) in Sicilian patients?” THE ROLE OF MICRORNAS IN DRIVING ... : A CHALLENGING TOOL FOR BREAST CANCER MANAGEMENT. Daniela Massihnia, Alessandro Perez, Viviana Bazan, Giuseppe ... NEGATIVE BREAST CANCER: SHEDDING LIGHT ONTO THE ROLE OF PI3K/AKT/MTOR PATHWAY. Daniela Massihnia1
-
117. Europass CV Listì (15%)
20-gen-2017 12.58.27”, Chieti, Italy Critical Review in Oncology/Hematology 9)TRIPLE NEGATIVE BREAST CANCER ... in molecular pathways mediating the anticancer effects of zoledronic acid in breast cancer ... chemotherapy influence MiRNAs expression profiles in triple negative breast cancer.Cangemi A.1, Perez A.1
-
118. Progetti di ricerca (15%)
18-mar-2024 8.31.56in linguaggio divulgativo; Progetto Ambito Preclinico: "Effective targeting of breast cancer ... - “Identification of molecular events underlying the resistance of breast cancer stem cells to anti-cancer ... of molecular events underlying the resistance of breast cancer stem cells to anti-cancer therapies"